manoalide and Angina-Pectoris

manoalide has been researched along with Angina-Pectoris* in 1 studies

Other Studies

1 other study(ies) available for manoalide and Angina-Pectoris

Article	Year
Effect of serum from cardiovascular patients on catalytic activity of secretory phospholipase A2 (IIA). Bulletin of experimental biology and medicine, 2006, Volume: 142, Issue:5 Incubation of patients' serum catalytically active by type IIA secretory phospholipase A2 (SP-IIA) with serum containing the enzyme in a high concentration but exhibiting no catalytic activity in 1:1 volume ratio led to a significant inhibition of SP-IIA catalytic activity. donor and patient sera with low levels of SP-IIA had no effect on the serum with SP-IIA activity under these conditions. However, the increase in the content of patients' serum with a low level of SP-IIA in the incubation mixture to 1:2 (v/v) and of donor serum to 1:3 (v/v) also led to blockade of SP-IIA catalytic activity. These results indicate that human serum contains an SP-IIA inhibitor and its concentration decreases significantly in sera with SP-IIA activity. Topics: Angina Pectoris; Catalysis; Enzyme Inhibitors; Group II Phospholipases A2; Humans; Phospholipases A; Phospholipases A2; Terpenes	2006

Article

Year

Effect of serum from cardiovascular patients on catalytic activity of secretory phospholipase A2 (IIA).

Bulletin of experimental biology and medicine, 2006, Volume: 142, Issue:5

Incubation of patients' serum catalytically active by type IIA secretory phospholipase A2 (SP-IIA) with serum containing the enzyme in a high concentration but exhibiting no catalytic activity in 1:1 volume ratio led to a significant inhibition of SP-IIA catalytic activity. donor and patient sera with low levels of SP-IIA had no effect on the serum with SP-IIA activity under these conditions. However, the increase in the content of patients' serum with a low level of SP-IIA in the incubation mixture to 1:2 (v/v) and of donor serum to 1:3 (v/v) also led to blockade of SP-IIA catalytic activity. These results indicate that human serum contains an SP-IIA inhibitor and its concentration decreases significantly in sera with SP-IIA activity.

Topics: Angina Pectoris; Catalysis; Enzyme Inhibitors; Group II Phospholipases A2; Humans; Phospholipases A; Phospholipases A2; Terpenes

2006